检索结果-南通市图书馆

Superior mesenteric venous thrombosis: Endovascular management and outcomes

World Journal of Clinical Cases 2022年第1期10卷 217-226页

作者： Khaled Alnahhal Beau B Toskich samuel nussbaum Zhuo Li Young Erben Albert G Hakaim Houssam Farres Department of Surgery Division of Vascular SurgeryMayo Clinic FloridaJacksonvilleFL 32224United States Department of Radiology Mayo Clinic FloridaJacksonvilleFL 32224United States Department of Biostatistics Mayo Clinic FloridaJacksonvilleFL 32224United States

BACKGROUND Superior mesenteric venous thrombosis(SMVT)is a rare but fatal condition that is typically treated initially with anticoagulation therapy,and if this fails,with endovascular ***,due to its rarity,there are not many studies that have explored the effectiveness of anticoagulation and endovascular therapies in treating *** To evaluate patients diagnosed with SMVT who received endovascular therapy in addition to anticoagulation and report technical and clinical *** A retrospective analysis of the patients who underwent endovascular treatment for SMVT at Mayo Clinic from 2000-2019 was *** success was defined as angiographic improvement in SMV flow after *** patency was defined as the interval from reestablishing mesenteric venous flow until the first repeat thrombotic event or need for additional *** patency was defined as successful restoration of flow after repeat intervention until rethrombosis or last *** adverse events were reported through Clavien-Dindo *** Twenty-four patients were included for *** median age at intervention was 60 years(35-74 years)and 16(67%)were *** patients presented with acute thrombosis(79.2%)and 5 with chronic thrombosis with acute manifestations(20.8%).The most commonly used endovascular modalities were thrombectomy in 12 patients(50.0%)and catheter-directed thrombolysis in 10 patients(41.7%).Technical success was achieved in 18 patients(75%).The 14-d and 30-d primary patency rates were 88.9%and 83.3%,*** events were reported in two patients(8.3%),one marked as grade IIIB,and 1 death marked as grade ***-year overall survival rate was 82%(58%-100%).CONCLUSION Endovascular intervention with anticoagulation appears to be effective for managing *** treatment combination may be considered as first-line therapy for SMVT management in select patients.

关键词： Superior mesenteric venous thrombosis Endovascular Anticoagulation Retrospective Thrombectomy Mesenteric Thrombolysis

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：